Showing results (91-100 of 105) with videos related to

Sort By:
Pageof 11
Annals of Neurology|January 24, 2022
B Cell Depletion and SARS-CoV-2 Vaccine Responses in Neuroimmunologic PatientsBarbara Kornek, Fritz Leutmezer, Paulus S Rommer, et al.
Annals of the Rheumatic Diseases|August 17, 2022
Immunogenicity and safety of a fourth COVID-19 vaccination in rituximab-treated patients: an open-label extension studyDaniel Mrak, Elisabeth Simader, Daniela Sieghart, et al.
Annals of the Rheumatic Diseases|January 14, 2022
Additional heterologous versus homologous booster vaccination in immunosuppressed patients without SARS-CoV-2 antibody seroconversion after primary mRNA vaccination: a randomised controlled trialMichael Bonelli, Daniel Mrak, Selma Tobudic, et al.
Lancet (London, England)|June 17, 2014
Losmapimod, a novel p38 mitogen-activated protein kinase inhibitor, in non-ST-segment elevation myocardial infarction: a randomised phase 2 trialL Kristin Newby, Michael S Marber, Chiara Melloni, et al.
The Lancet. Microbe|June 8, 2026
Widespread circulation of Alongshan virus in Austria and serological evidence for infection in humans: a nationwide molecular and serological observational studyDavid M Florian, Paul Jetzinger, Anna-Margarita Schötta, et al.
Annals of the Rheumatic Diseases|September 15, 2022
Safety and immunogenicity of a third COVID-19 vaccination in patients with immune-mediated inflammatory diseases compared with healthy controlsFelix Kartnig, Daniel Mrak, Elisabeth Simader, et al.
JACC. Cardiovascular Interventions|August 23, 2014
A registry-based randomized trial comparing radial and femoral approaches in women undergoing percutaneous coronary intervention: the SAFE-PCI for Women (Study of Access Site for Enhancement of PCI for Women) trialSunil V Rao, Connie N Hess, Britt Barham, et al.
JAMA Internal Medicine|December 20, 2021
Comparison of SARS-CoV-2 Antibody Response 4 Weeks After Homologous vs Heterologous Third Vaccine Dose in Kidney Transplant Recipients: A Randomized Clinical TrialRoman Reindl-Schwaighofer, Andreas Heinzel, Manuel Mayrdorfer, et al.
Scientific Reports|November 23, 2022
The systemic renin-angiotensin system in COVID-19Roman Reindl-Schwaighofer, Sebastian Hödlmoser, Oliver Domenig, et al.
The Journal of Experimental Medicine|September 24, 2024
Autoantibodies neutralizing type I IFNs underlie severe tick-borne encephalitis in ∼10% of patientsAdrian Gervais, Astrid Marchal, Andrea Fortova, et al.
Pageof 11